The customer contacted a siemens customer care center (ccc) and reported that a discordant, falsely low activated partial thromboplastin time (aptt) result was obtained on a patient sample on a bcs xp system using dade actin fsl activated ptt reagent.The customer was performing correlation studies with a new lot of actin fsl at the time of the discrepant patient result.A new lot of reagent that was being used for crossover studies was mixed with the current lot of reagent.Both current and new lots of reagent were both set as current on the system, and the system was potentially using the wrong reagents.Both current and new lots of reagent could have also potentially been blended together.This is off label use of the dade actin fsl activated ptt reagent.Quality controls (qc) were later run and recovered within range.Additionally, more than 30 patient samples were then run on the affected bcs xp system, and no other issues were found.The reagent is performing according to specifications.No further evaluation of this device is required.
|
A discordant, falsely low activated partial thromboplastin time (aptt) result was obtained on a patient sample on a bcs xp system serial number: (b)(4) using dade actin fsl activated ptt reagent (lot number: 556936).The discordant result was reported to the physician(s).The customer later questioned the initial result.The original patient sample was repeated for aptt twice using the same bcs xp system serial number: (b)(4), resulting higher.The same sample was then repeated for aptt twice using an alternate bcs xp system serial number: (b)(4), resulting higher and confirming the repeat results from the first bcs xp system serial number: (b)(4).The repeat results from bcs xp system serial number: (b)(4) were reported, as the correct results, to the physician(s).There are no reports of patient intervention or adverse health consequences due to the discordant, falsely low aptt result.
|